Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Trastornos del movimiento Movement disorders 79 artículos Viendo del 1 al 40 de 79 artículos
Pub MED

Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study.NUEVO

Desai N, Patel PB, Shah S, Patel TK, Shah SN, Vatsala E.
Int J Psychiatry Clin Pract. 2017 Sep 27:1-8. doi: 10.1080/13651501.2017.1381268. [Epub ahead of print]
Pub MED

ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.NUEVO

Subramaniam RM, Frey KA, Hunt CH, Mercier GA Jr, Solnes LB, Colletti PM, Lu Y, Savir-Baruch B, Williams HT.
Clin Nucl Med. 2017 Sep 15. doi: 10.1097/RLU.0000000000001815. [Epub ahead of print]
Pub MED

Movement disorders: an update.NUEVO

Tasker RC.
Curr Opin Pediatr. 2017 Sep 12. doi: 10.1097/MOP.0000000000000545. [Epub ahead of print] No abstract available.
Pub MED

The neurophysiology of paediatric movement disorders.NUEVO

McClelland VM.
Curr Opin Pediatr. 2017 Sep 12. doi: 10.1097/MOP.0000000000000547. [Epub ahead of print]
Pub MED

Movement disorders in genetically confirmed mitochondrial disease and the putative role of the cerebellum.NUEVO

Schreglmann SR, Riederer F, Galovic M, Ganos C, Kägi G, Waldvogel D, Jaunmuktane Z, Schaller A, Hidding U, Krasemann E, Michels L, Baumann CR, Bhatia K, Jung HH.
Mov Disord. 2017 Sep 13. doi: 10.1002/mds.27174. [Epub ahead of print]
Pub MED

An update on new and unique uses of botulinum toxin in movement disorders.NUEVO

Jankovic J.
Toxicon. 2017 Sep 6. pii: S0041-0101(17)30276-3. doi: 10.1016/j.toxicon.2017.09.003. [Epub ahead of print]
Pub MED

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.NUEVO

[No authors listed]
Mov Disord. 2017 Sep;32(9):e1-e19. doi: 10.1002/mds.27134. No abstract available.
Pub MED

Treatable inherited rare movement disorders.NUEVO

Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodríguez-Violante M, Schöls L, Stamelou M, et al.
Mov Disord. 2017 Sep 1. doi: 10.1002/mds.27140. [Epub ahead of print] Review.
Pub MED

Cognitive dysfunction and symptoms of movement disorders in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.

Ikeuchi T, Mezaki N, Miura T.
Parkinsonism Relat Disord. 2017 Aug 16. pii: S1353-8020(17)30299-7. doi: 10.1016/j.parkreldis.2017.08.018. [Epub ahead of print]
Pub MED

Restless Legs Syndrome and Sleep-Related Movement Disorders.

Trotti LM.
Continuum (Minneap Minn). 2017 Aug;23(4, Sleep Neurology):1005-1016. doi: 10.1212/CON.0000000000000488.
Pub MED

[Deep brain stimulation in movement disorders: evidence and therapy standards].

Parpaley Y, Skodda S.
Fortschr Neurol Psychiatr. 2017 Jul;85(7):414-431. doi: 10.1055/s-0043-113136. Epub 2017 Aug 2. German.
Pub MED

Functional movement disorders.

Barbey A, Aybek S.
Curr Opin Neurol. 2017 Aug;30(4):427-434. doi: 10.1097/WCO.0000000000000464.
Pub MED

Sleep-related movement disorders and disturbances of motor control.

Bargiotas P, Bassetti CL.
Curr Opin Neurol. 2017 Aug;30(4):405-415. doi: 10.1097/WCO.0000000000000466.
Pub MED

Clinical utility and research frontiers of neuroimaging in movement disorders.

Nobili FM, Westman E, Meles SK, Pereira JB, Massa F, Grazzini M, Kogan RV, Leenders KL.
Q J Nucl Med Mol Imaging. 2017 Aug 28. doi: 10.23736/S1824-4785.17.03018-7. [Epub ahead of print]
Pub MED

Infection-mediated autoimmune movement disorders.

Cucca A, Migdadi HA, Di Rocco A.
Parkinsonism Relat Disord. 2017 Jul 21. pii: S1353-8020(17)30266-3. doi: 10.1016/j.parkreldis.2017.07.019. [Epub ahead of print]
Pub MED

Novel Eye Movement Disorders in Whipple's Disease-Staircase Horizontal Saccades, Gaze-Evoked Nystagmus, and Esotropia.

Shaikh AG, Ghasia FF.
Front Neurol. 2017 Jul 11;8:321. doi: 10.3389/fneur.2017.00321. eCollection 2017.
Pub MED

Verb naming fluency in hypokinetic and hyperkinetic movement disorders.

Bayram E, Akbostanci MC.
Cortex. 2017 Jul 1. pii: S0010-9452(17)30203-4. doi: 10.1016/j.cortex.2017.06.014. [Epub ahead of print]
Pub MED

Eye Movement Disorders Following Allogeneic Bone Marrow Transplantation on FK506 (Tacrolimus) and Ganciclovir.

Karagun BS, Akbas T, Arpaci T, Antmen B.
J Pediatr Hematol Oncol. 2017 Jul 20. doi: 10.1097/MPH.0000000000000870. [Epub ahead of print]
Pub MED

What would Dr. James Parkinson think today? The 21st Annual Congress of the International Parkinson's disease and movement disorders society.

Obeso JA, Trenkwalder C.
Mov Disord. 2017 Jul;32(7):951-954. doi: 10.1002/mds.27108. No abstract available.
Pub MED

The most promising advances in our understanding and treatment of functional (psychogenic) movement disorders.

Hallett M.
Parkinsonism Relat Disord. 2017 Jul 8. pii: S1353-8020(17)30235-3. doi: 10.1016/j.parkreldis.2017.07.002. [Epub ahead of print]
Pub MED

Psychiatric comorbidities in movement disorders.

Miguel-Puga A, Villafuerte G, Arias-Carrión O.
Int Rev Psychiatry. 2017 Jul 6:1-11. doi: 10.1080/09540261.2017.1322043. [Epub ahead of print]
Pub MED

Dystonia as an unusual presentation of systemic mastocytosis: possible link between histamine release and movement disorders.

Phillips A, Hoyte FCL, Leung DYM.
J Allergy Clin Immunol Pract. 2017 Jul 27. pii: S2213-2198(17)30430-0. doi: 10.1016/j.jaip.2017.06.005. [Epub ahead of print] No abstract available.
Pub MED

Adaptive Deep Brain Stimulation for Movement Disorders: The Long Road to Clinical Therapy.

Meidahl AC, Tinkhauser G, Herz DM, Cagnan H, Debarros J, Brown P.
Mov Disord. 2017 Jun;32(6):810-819. doi: 10.1002/mds.27022. Review.
Pub MED

Seventy years with the globus pallidus: Pallidal surgery for movement disorders between 1947 and 2017.

Cif L, Hariz M.
Mov Disord. 2017 Jun 7. doi: 10.1002/mds.27054. [Epub ahead of print] Review.
Pub MED

Abstracts of the 21(st) International Congress of Parkinson's Disease and Movement Disorders.

[No authors listed]
Mov Disord. 2017 Jun;32 Suppl 2:S1-S1079. doi: 10.1002/mds.27087. No abstract available.
Pub MED

A Comprehensive Approach to Deep Brain Stimulation for Movement Disorders.

Akbar U, Asaad WF.
R I Med J (2013). 2017 Jun 1;100(6):30-33.
Pub MED

The Moving Rubber Hand Illusion Reveals that Explicit Sense of Agency for Tapping Movements Is Preserved in Functional Movement Disorders.

Marotta A, Bombieri F, Zampini M, Schena F, Dallocchio C, Fiorio M, Tinazzi M.
Front Hum Neurosci. 2017 Jun 6;11:291. doi: 10.3389/fnhum.2017.00291. eCollection 2017.
Pub MED

A Retrospective Study of Pimavanserin Use in a Movement Disorders Clinic.

Friedman JH.
Clin Neuropharmacol. 2017 Jun 16. doi: 10.1097/WNF.0000000000000219. [Epub ahead of print]
Pub MED

Treatment of Movement Disorders With Focused Ultrasound.

Fishman PS, Frenkel V.
J Cent Nerv Syst Dis. 2017 Jun 6;9:1179573517705670. doi: 10.1177/1179573517705670. eCollection 2017. Review.
Pub MED

Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research.

Wichmann T, Bergman H, DeLong MR.
J Neural Transm (Vienna). 2017 Jun 10. doi: 10.1007/s00702-017-1736-5. [Epub ahead of print] Review.
Pub MED

Movement disorders in anti-NMDA receptor encephalitis.

Servais E, Fastre S, Hantson P.
Neurol India. 2017 May-Jun;65(3):632-633. doi: 10.4103/neuroindia.NI_739_16. No abstract available.
Pub MED

The potential impact of sleep-related movement disorders on stroke risk: a population-based longitudinal study.

Chou CH, Yin JH, Chen SY, Lin CC, Sung YF, Chung CH, Chien WC, Tsai CK, Tsai CL, Lin GY, Lin YK, Lee JT.
QJM. 2017 May 8. doi: 10.1093/qjmed/hcx097. [Epub ahead of print]
Pub MED

Diagnostic performance of the visual reading of (123)I-ioflupane SPECT images when assessed with or without quantification in patients with movement disorders or dementia.

Booij J, Dubroff J, Pryma D, Yu JQ, Agarwal R, Lakhani P, Kuo PH.
J Nucl Med. 2017 May 4. pii: jnumed.116.189266. doi: 10.2967/jnumed.116.189266. [Epub ahead of print]
Pub MED

A review of psychiatric co-morbidity described in genetic and immune mediated movement disorders.

Peall KJ, Lorentzos MS, Heyman I, Tijssen MAJ, Owen MJ, Dale RC, Kurian MA.
Neurosci Biobehav Rev. 2017 May 18;80:23-35. doi: 10.1016/j.neubiorev.2017.05.014. [Epub ahead of print] Review.
Pub MED

Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force.

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C.
Mov Disord. 2017 May;32(5):724-725. doi: 10.1002/mds.27045. No abstract available.
Pub MED

ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.

Carecchio M, Mencacci NE, Iodice A, Pons R, Panteghini C, Zorzi G, Zibordi F, Bonakis A, Dinopoulos A, Jankovic J, Stefanis L, Bhatia KP, Monti V, R'Bibo L, Veneziano L, Garavaglia B, Fusco C, Wood N, Stamelou M, Nardocci N.
Parkinsonism Relat Disord. 2017 May 10. pii: S1353-8020(17)30166-9. doi: 10.1016/j.parkreldis.2017.05.004. [Epub ahead of print]
Pub MED

Inter-rater variability in motor function assessment in Parkinson's disease between experts in movement disorders and nurses specialising in PD management.

de Deus Fonticoba T, Santos García D, Macías Arribí M.
Neurologia. 2017 May 23. pii: S0213-4853(17)30162-7. doi: 10.1016/j.nrl.2017.03.005. [Epub ahead of print] English, Spanish.
Pub MED

[Genetic risk variants in Parkinson's disease and other movement disorders].

Brockmann K, Lohmann K.
Nervenarzt. 2017 May 23. doi: 10.1007/s00115-017-0348-5. [Epub ahead of print] Review. German.
Pub MED

Impaired sense of agency in functional movement disorders: An fMRI study.

Nahab FB, Kundu P, Maurer C, Shen Q, Hallett M.
PLoS One. 2017 Apr 27;12(4):e0172502. doi: 10.1371/journal.pone.0172502. eCollection 2017.
Pub MED

Neuroprotective Effects of Exercise on Brain Edema and Neurological Movement Disorders Following the Cerebral Ischemia and Reperfusion in Rats.

Shamsaei N, Erfani S, Fereidoni M, Shahbazi A.
Basic Clin Neurosci. 2017 Jan;8(1):77-84. doi: 10.15412/J.BCN.03080110.
Viendo del 1 al 40 de 79 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.